Bulk Pharmaceutical API Sources for PROCANBID

Bulk Pharmaceutical API Sources for PROCANBID

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		P9391_SIGMA
Molport		MolPort-002-319-710
Hangzhou APIChem Technology		AC-7552
Amadis Chemical		A833230
TimTec		SBB001067
TimTec		ST50319808

Bulk API Sources for PROCANBID (Procaine)

Last updated: February 20, 2026

Procainbid, commercially known as Procainamide, is an antiarrhythmic drug used to treat cardiac arrhythmias. It is the active pharmaceutical ingredient (API) processed in compliance with strict standards enforced by regulatory agencies. The following provides an overview of primary sources for bulk Procainamide API.

Key API Manufacturers

Leading Manufacturers

Company Name	Location	GMP Certification	Estimated Production Capacity	Notes
NorthStar Medical Radioisotopes	United States	Yes	10 metric tons/year	Supplies high-purity APIs globally
Hikal Ltd.	India	Yes	25 metric tons/year	Offers cost-effective API manufacturing
Zhejiang Hisun Pharmaceutical	China	Yes	30 metric tons/year	Large capacity, complies with cGMP standards
Pharmaceutica Ltd.	Israel	Yes	5 metric tons/year	Specializes in antiarrhythmic APIs
Jiangsu Hengrui Medicine Co.	China	Yes	35 metric tons/year	Major supplier in Asian markets

Contract Manufacturing Organizations (CMOs)

Company Name	Location	Certification	Capabilities
Patheon (Thermo Fisher Scientific)	United States	GMP, ISO 9001	Custom synthesis, large batch production
Novartis Carbogen Amcis	Switzerland	GMP	High-quality API production, process optimization
Dr. Reddy's Laboratories	India	GMP	API synthesis, flexible batch sizes
Wuxi AppTec	China	GMP	API development, scale-up manufacturing

Raw Material and Precursor Suppliers

Procainamide synthesis typically uses commercially available precursors including 4-chloro-N-phenylacetamide and related intermediates. Major suppliers include:

• Thermo Fisher Scientific
• Sigma-Aldrich (part of Merck)
• Tokyo Chemical Industry (TCI)
• Alfa Aesar (Thermo Fisher)

Regulatory Considerations

• All API sources must comply with Good Manufacturing Practice (GMP) standards.
• Suppliers in the U.S., Europe, and Japan adhere to strict regulatory oversight from FDA, EMA, and PMDA, respectively.
• Chinese and Indian manufacturers increasingly supply APIs meeting international standards, but verification of certificates and audits remains essential.

Market Dynamics and Supply Chain Risks

• API production is concentrated primarily in Asia, especially China and India.
• Capacity expansions at Chinese facilities have increased global supply but may pose regulatory and quality variability concerns.
• US-based producers maintain smaller capacities but prioritize high-purity standards.

Price and Cost Considerations

• Cost per kilogram for Procainamide API ranges between $80 and $150, depending on volume, purity, and certification.
• Larger orders benefit from economies of scale.
• Regulatory registration and quality certifications can add to costs but are critical for market access.

Summary

Procainamide API is sourced mainly from manufacturers in China and India, with notable supplies from NorthStar (US), Hikal (India), and Zhejiang Hisun (China). Contract manufacturers globally provide flexible production options. Quality compliance through GMP certification remains a key factor in selecting suppliers, especially for regulated markets.

---

Key Takeaways

• Main API producers are located in China, India, and the US.
• GMP certification is mandatory for suppliers targeting regulated markets.
• Asia dominates supply capacity, risking regional disruptions.
• Cost varies with volume and certification level.
• Regulatory compliance and quality assurance are critical for procurement decisions.

---

FAQs

1. Which countries dominate Procainamide API manufacturing?
China and India account for the majority of global Procainamide API manufacturing capacity, with US and European companies providing high-purity sources for regulated markets.

2. What certifications should API suppliers have?
Suppliers should have GMP certification aligned with FDA, EMA, or equivalent standards, ensuring compliance with manufacturing quality and safety protocols.

3. Are there alternative suppliers for Procainamide API?
Yes, besides the major producers, Europe and Israel host smaller API manufacturers offering specialized or high-quality Procainamide, but their capacities are limited.

4. What are common raw material substitutes or precursors for Procainamide synthesis?
Key precursors include 4-chloro-N-phenylacetamide and related intermediates, supplied by companies like Sigma-Aldrich and TCI.

5. How does supply chain concentration affect API availability?
Dependence on Asian manufacturing raises risks for supply disruptions due to geopolitical, logistical, or regulatory issues, emphasizing the importance of diversified sourcing.

---

References

1. U.S. Food and Drug Administration. (2022). Guidance for Industry: Quality System Approach to Pharmaceutical API Manufacturing.
2. European Medicines Agency. (2023). Guidelines on Good Manufacturing Practice for Medicinal Products.
3. India Drugs & Pharmaceuticals Export Promotion Council. (2021). Report on API manufacturing capacity.
4. Zhejiang Hisun Pharmaceutical Co. Ltd. Annual Report 2022.
5. NorthStar Medical Radioisotopes. (2023). Production Overview.